FDA “Draft Guidance” Suppresses Critical Health Care Information

By Marc J. Scheineson, head of the food and drug practice at the law firm Reed Smith Shaw and McClay from its Washington, D.C. office, and a former FDA Associate Commissioner for Legislative Affairs, and Katherine Chen, a food and drug associate at the firm.